RxDoctor Payments Data

Steven Sanders, MD

Family Medicine · Gadsden, ALNPI 1508874512

Payments from drug & device makers

$2,548in general payments, 2019–2025

Across 109 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$627
  • GSK$471
  • Merck$283
  • Novo Nordisk$258
  • Boehringer Ingelheim$229
  • Novartis$187
  • plus $493 from 9 others

What the payments were for

  • Food & beverage$2,50998%
  • Education$392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,548 in reported general payments places this provider in the 70th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$84,923
Medicare patients
266
Services billed
1,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol341$232,605
OzempicSemaglutide166$176,517
JardianceEmpagliflozin223$164,895
MounjaroTirzepatide138$145,305
EliquisApixaban128$93,568
Trelegy ElliptaFluticasone/Umeclidin/Vilanter79$58,096
EntrestoSacubitril/Valsartan47$50,060
XareltoRivaroxaban25$26,254
Breztri AerosphereBudesonide/Glycopyr/Formoterol37$24,452
InvokanaCanagliflozin27$23,493
Soliqua 100-33Insulin Glargine/Lixisenatide47$19,500
Atorvastatin Calcium994$14,545
JanuviaSitagliptin Phosphate23$12,720
Tresiba Flextouch U-100Insulin Degludec21$12,165
Levothyroxine Sodium592$10,964

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$627$257,057378 claims
Novo NordiskOzempic$258$176,517166 claims
Boehringer IngelheimJardiance, Spiriva Respimat$229$173,234240 claims
Lilly USA, LLCMounjaro$112$145,305138 claims
PfizerEliquis$80$93,568128 claims
GSKTrelegy Ellipta$471$58,09679 claims
NovartisEntresto$187$50,06047 claims
Johnson & JohnsonXarelto, Invokana$40$49,74852 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$74$19,50047 claims
MerckJanuvia$283$12,72023 claims
Astellas Pharma US IncMyrbetriq$66$10,83311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Gadsden

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →